IPP Bureau
Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
By IPP Bureau - September 14, 2023
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
Bajaj Healthcare announces receipt of EIR from USFDA
By IPP Bureau - September 14, 2023
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform
By IPP Bureau - September 14, 2023
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Qure.ai teams up with PATH India
By IPP Bureau - September 14, 2023
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
Philips extends its mobile C-arm range with Zenition 30
By IPP Bureau - September 14, 2023
Alleviating staff shortages by empowering surgeons with greater personalization and control
Sir H. N. Reliance Foundation Hospital launches Sepsis Cart
By IPP Bureau - September 14, 2023
The hospital hosted a two-day event with top internal and external faculty and medical experts
Zydus receives EIR for injectables manufacturing facility at Zydus Biotech Park, Ahmedabad
By IPP Bureau - September 14, 2023
The inspection was a cGMP Inspection and had ended with NIL observations
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right.jpg "Takara Bio Europe launches high-quality enzymes suitable for pre-clinical mRNA vaccine")
Takara Bio Europe launches high-quality enzymes suitable for pre-clinical mRNA vaccine
By IPP Bureau - September 13, 2023
AI to transform all processes in drug development by 2026, predicts CPHI Report
By IPP Bureau - September 13, 2023
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
President Murmu to virtually launch Ayushman Bhav Campaign today
By IPP Bureau - September 13, 2023
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
IIT Kanpur signs MoU with Sensa Core for technology transfer of novel strip to analyse bilirubin in human blood
By IPP Bureau - September 13, 2023
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
By IPP Bureau - September 12, 2023
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
By IPP Bureau - September 12, 2023
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Mpower unveils COPE to empower students to champion mental health in colleges
By IPP Bureau - September 12, 2023
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
